1. Home
  2. KELYB vs ESPR Comparison

KELYB vs ESPR Comparison

Compare KELYB & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KELYB
  • ESPR
  • Stock Information
  • Founded
  • KELYB 1946
  • ESPR 2008
  • Country
  • KELYB United States
  • ESPR United States
  • Employees
  • KELYB N/A
  • ESPR N/A
  • Industry
  • KELYB Professional Services
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • KELYB Consumer Discretionary
  • ESPR Health Care
  • Exchange
  • KELYB Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • KELYB 483.4M
  • ESPR 445.6M
  • IPO Year
  • KELYB N/A
  • ESPR 2013
  • Fundamental
  • Price
  • KELYB $13.84
  • ESPR $2.84
  • Analyst Decision
  • KELYB
  • ESPR Buy
  • Analyst Count
  • KELYB 0
  • ESPR 6
  • Target Price
  • KELYB N/A
  • ESPR $6.50
  • AVG Volume (30 Days)
  • KELYB 341.0
  • ESPR 6.1M
  • Earning Date
  • KELYB 11-06-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • KELYB 2.17%
  • ESPR N/A
  • EPS Growth
  • KELYB N/A
  • ESPR N/A
  • EPS
  • KELYB N/A
  • ESPR N/A
  • Revenue
  • KELYB $4,495,900,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • KELYB $6.05
  • ESPR $10.59
  • Revenue Next Year
  • KELYB $4.18
  • ESPR N/A
  • P/E Ratio
  • KELYB N/A
  • ESPR N/A
  • Revenue Growth
  • KELYB 0.97
  • ESPR N/A
  • 52 Week Low
  • KELYB $11.04
  • ESPR $0.69
  • 52 Week High
  • KELYB $21.22
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • KELYB 52.45
  • ESPR 79.27
  • Support Level
  • KELYB $14.00
  • ESPR $2.37
  • Resistance Level
  • KELYB $15.05
  • ESPR $2.73
  • Average True Range (ATR)
  • KELYB 0.00
  • ESPR 0.17
  • MACD
  • KELYB -0.13
  • ESPR 0.03
  • Stochastic Oscillator
  • KELYB 12.87
  • ESPR 93.75

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: